Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5222
Title: AVP-786 as a promising treatment option for Alzheimer's Disease including agitation
Authors: Khoury, Rita
Marx, Charlotte
Mirgati, Sidney
Velury, Divya
Chakkamparambil, Binu
Grossberg, George T
Affiliations: Faculty of Medicine 
Keywords: Agitation
Alzheimer’s Disease
avp-786
Deuteration
Dextromethorphan
Efficacy
Pharmacology
Quinidine
Safety
Tolerability
Issue Date: 2021
Publisher: Taylor & Francis Online
Part of: Expert Opinion on Pharmacotherapy
Volume: 22
Issue: 7
Start page: 783
End page: 795
Abstract: 
To date, there is no FDA-approved treatment for agitation in Alzheimer's disease (AD). Medications currently used off-label have modest clinical efficacy and serious side effects.
URI: https://scholarhub.balamand.edu.lb/handle/uob/5222
ISSN: 14656566
DOI: 10.1080/14656566.2021.1882995
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

SCOPUSTM   
Citations

9
checked on Dec 3, 2022

Record view(s)

23
checked on Dec 2, 2022

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.